 |
|
CONSIDERATION OF MULTIPLE VARIABLES IN EVALUATION OF HYPOTENSIVE DRUGS
Alvin P. Shapiro, M.D.
J Am Med Assoc. 1956;160(1):30-39.
Abstract
• Hypotensive agents were administered to a series of patients, some hospitalized, some ambulatory, with hypertensive disease of all degrees of severity. The drugs were given in sufficient dosage to produce either an apparent lowering of blood pressure or undesirable side-effects. Special efforts were made not only to standardize the conditions under which the blood pressures were read but also to determine the spontaneous course of the disease in each individual, to randomize the assignment of drugs and placebos, and to keep ward physicians and nurses from being influenced by a knowledge of the nature of the medication. Of the drugs that were tried, none were demonstrated to have a specific role in the treatment of hypertensive vascular disease.
Author Affiliations
Dallas, Texas
From the Department of Internal Medicine, the University of Texas, Southwestern Medical School.
Footnotes
Read in part at the Annual Meeting, American Psychosomatic Society, New Orleans, March 28, 1954.
Rau-Tabs, the alseroxylon fraction of Rauwolfia serpentina, was supplied by the National Drug Company, Philadelphia. Veralba was supplied by Pitman-Moore Company, Indianapolis.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Clinical Use of Ambulatory Blood Pressure Monitoring: A Review of Value in Patient Care
Shapiro et al.
Arch Fam Med 1995;4:691-696.
ABSTRACT
Refractory Hypertension in an Otherwise Healthy Adolescent
Davis et al.
CLIN PEDIATR 1981;20:587-590.
ABSTRACT
Behavioral Methods in the Treatment of Hypertension: A Review of Their Clinical Status
SHAPIRO et al.
ANN INTERN MED 1977;86:626-636.
ABSTRACT
Technique of Controlled Drug Assay: IV. Comparison of Guanethidine, Methyldopa, and a Placebo in the Hypertensive Negro Woman
Levine et al.
Arch Intern Med 1968;122:305-310.
ABSTRACT
|
